Recent Development of DNA Gyrase Inhibitors: An Update

Area of Science:

• Microbiology
• Pharmacology
• Medicinal Chemistry

Background:

• Antimicrobial resistance (AMR) is a critical global health challenge, rendering existing treatments ineffective.
• Bacterial and fungal infections persist and grow when standard drug regimens fail due to resistance.
• Emerging resistance necessitates novel therapeutic strategies beyond conventional antibiotics like Ciprofloxacin and Novobiocin.

Purpose of the Study:

• To review recent advancements in synthetic and natural DNA gyrase inhibitors.
• To evaluate the potential of these agents in overcoming antimicrobial resistance.
• To present information on molecules currently in clinical trials and their status.

Main Methods:

• Literature review of synthetic and natural DNA gyrase inhibitors.
• Analysis of Structure-Activity Relationships (SAR) for identified agents.
• Examination of mechanisms of action for novel antimicrobial compounds.

Main Results:

• Several novel synthetic and natural DNA gyrase inhibitors demonstrate significant potential against resistant microbes.
• Agents targeting different sites on DNA gyrase, such as Zodiflodacin and Zenoxacin, have shown success.
• Ongoing clinical trials are evaluating the efficacy and safety of promising new molecules.

Conclusions:

• DNA gyrase remains a viable and crucial target for developing new antimicrobial agents.
• Continued research into novel inhibitors is essential to combat the growing threat of antimicrobial resistance.
• Understanding SAR and mechanisms of action will guide the design of more effective treatments.